Autoimmune hemolytic anemia (AIHA) is a condition whereby the red blood cells are destroyed by the immune system. In France, the incidence rate of paediatric forms is estimated to be 0.8 cases per 100,000 children and adolescents aged under 18, which amounts to 20 to 30 new cases per year in France. Another autoimmune disease or underlying primary immune deficiency may appear in the diagnosis or several months or years later.

ORPHA98375 – Autoimmune hemolytic anemia
ORPHA1959 – Evans syndrome
ORPHA90033 – Autoimmune hemolytic anemia, warm type
ORPHA90036 – Mixed-type autoimmune hemolytic anemia

ORPHA90037 – Drug-induced autoimmune hemolytic anemia
ORPHA228312 – Autoimmune hemolytic anemia, cold type
ORPHA56425 – Cold agglutinin disease

ORPHA90035 – Paroxysmal cold hemoglobinuria
ORPHA438159 – STAT3-related early-onset multisystem autoimmune disease


Expert opinions list

Main healthcare centres


Click on a bullet to view details of a healthcare centre

Centre of reference coordinator / Centre of reference constituentCompetence centreAssociated centre Undefined
Speciality : Adult Pediatric